Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis

Non-small-cell lung cancer (NSCLC) is an aggressive malignancy and long-term survival remains unsatisfactory for patients with metastatic and recurrent disease. Repurposing the anti-malarial drug dihydroartemisinin (DHA) has been proved to possess potent antitumor effect on various cancers. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jie, Geng, Guojun, Yu, Xiuyi, Liu, Hongming, Gao, Jing, An, Hanxiang, Cai, Chengfu, Li, Ning, Shen, Dongyan, Wu, Xiaoqiang, Zheng, Lisheng, Mi, Yanjun, Yang, Shuyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349987/
https://www.ncbi.nlm.nih.gov/pubmed/27895313
http://dx.doi.org/10.18632/oncotarget.13536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349987/
https://www.ncbi.nlm.nih.gov/pubmed/27895313
http://dx.doi.org/10.18632/oncotarget.13536

Ejemplares similares